Meditation or music before magic mushrooms? UCL tests digital prep for psychedelics

NCT ID NCT06815653

First seen Dec 04, 2025

Summary

This study tests a 21-day digital program that uses either meditation or music to prepare healthy volunteers for a supervised psilocybin session. Forty people will be randomly assigned to one of the two preparation methods. The main goal is to see if the program is practical and easy to follow, not to measure health benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University College London

    RECRUITING

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Psilocybin (25 mg single dose)

What this could lead to

If successful, this could show that a simple digital preparation program helps people have safer, more meaningful psychedelic experiences, potentially improving future therapy protocols.

What could go wrong

This is a very early feasibility study with only 40 healthy volunteers, not patients. It is not designed to prove any treatment effect, and the results may not apply to clinical settings.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.